Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, Taiwan
Cheng-Hsun Chiu* , Michael Waddingdon†, Wu-Shiun Hsieh*, David Greenberg‡, Paul C. Schreckenberger§, and Amy M. Carnahan¶
Author affiliations: *Chang Gung Children's Hospital, Taoyuan, Taiwan; †Accugenix, Inc., Newark, Delaware; ‡British Columbia's Children's Hospital, Vancouver, British Columbia, Canada; §University of Illinois at Chicago Medical Center, Chicago, Illinois, USA; ¶University of Maryland School of Medicine, Baltimore, Maryland, USA
Figure 2. Random amplified polymorphic DNA fingerprinting (RAPD) types generated by arbitrarily primed PCR. Lanes 5-8 show results for the four index strains of the atypical Chryseobacterium meningosepticum, 96, 97-1, 97-2, and 97-3, respectively; lanes 1-4, four clinical isolates of C. meningosepticum from Canada; lanes 9-10, two clinical isolates of B. cepacia; lane 11, P. aeruginosa strain P1; and lane 12, clinical isolate of K. pneumoniae. Lane M shows the 1-kb DNA ladder.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.